Zacks Research Has Pessimistic Opinion of BAX Q4 Earnings

Baxter International Inc. (NYSE:BAX – Free Report) – Equities researchers at Zacks Research cut their Q4 2026 earnings per share estimates for shares of Baxter International in a research note issued to investors on Thursday, November 19th. Zacks Research analyst Team now expects that the medical instruments supplier will post earnings of $0.59 per share for the quarter, down from their previous estimate of $0.60. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.10 per share. Zacks Research also issued estimates for Baxter International’s Q1 2028 earnings at $0.44 EPS.

Other research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. reduced their target price on shares of Baxter International from $26.00 to $25.00 and set a “neutral” rating for the company in a report on Friday, October 30th. UBS Group raised their target price on shares of Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research report on Tuesday, July 28th. Jefferies Financial Group reiterated a “hold” rating and issued a $25.00 price target on shares of Baxter International in a research note on Thursday, October 29th. TD Cowen boosted their price target on shares of Baxter International from $20.00 to $24.00 and gave the stock a “hold” rating in a research report on Monday, July 27th. Finally, Wells Fargo & Company boosted their price target on shares of Baxter International from $23.00 to $25.00 and gave the stock an “equal weight” rating in a research report on Friday, October 30th. One analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $23.27.

Get Our Latest Stock Analysis on Baxter International

Baxter International Price Performance

NYSE BAX opened at $25.38 on Friday. The company has a quick ratio of 1.19, a current ratio of 1.79 and a debt-to-equity ratio of 1.20. Baxter International has a 12-month low of $15.73 and a 12-month high of $30.00. The company has a market capitalization of $13.13 billion, a PE ratio of -18.00, a price-to-earnings-growth ratio of 3.84 and a beta of 0.68. The firm’s 50 day moving average is $24.61 and its 200-day moving average is $21.79.

Baxter International (NYSE:BAX – Get Free Report) last released its quarterly earnings results on Thursday, October 29th. The medical instruments supplier reported $0.58 earnings per share for the quarter, topping analysts’ consensus estimates of $0.52 by $0.06. The firm had revenue of $2.98 billion during the quarter, compared to the consensus estimate of $2.91 billion. Baxter International had a positive return on equity of 16.23% and a negative net margin of 6.23%. The business’s revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.69 EPS.

Institutional Investors Weigh In On Baxter International

Institutional investors and hedge funds have recently made changes to their positions in the stock. Jones Financial Companies Lllp bought a new stake in shares of Baxter International during the 2nd quarter worth approximately $26,000. Nemes Rush Group LLC boosted its holdings in shares of Baxter International by 2,915.9% in the 3rd quarter. Nemes Rush Group LLC now owns 1,327 shares of the medical instruments supplier’s stock valued at $32,000 after buying an additional 1,283 shares during the last quarter. Global Retirement Partners LLC grew its stake in shares of Baxter International by 45.8% in the third quarter. Global Retirement Partners LLC now owns 1,566 shares of the medical instruments supplier’s stock valued at $38,000 after buying an additional 492 shares in the last quarter. CYBER HORNET ETFs LLC grew its stake in shares of Baxter International by 52.4% in the second quarter. CYBER HORNET ETFs LLC now owns 2,153 shares of the medical instruments supplier’s stock valued at $46,000 after buying an additional 740 shares in the last quarter. Finally, Community Bank N.A. bought a new position in shares of Baxter International in the second quarter valued at $46,000. Institutional investors own 90.19% of the company’s stock.

Baxter International Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, January 4th. Shareholders of record on Friday, November 27th will be given a dividend of $0.01 per share. The ex-dividend date of this dividend is Friday, November 27th. This represents a $0.04 annualized dividend and a dividend yield of 0.2%. Baxter International’s payout ratio is -2.84%.

Baxter International Company Profile

(Get Free Report)

Baxter International is a global healthcare company that develops and supplies products used in hospitals, clinics and other care settings. Its offerings include intravenous solutions and administration sets, infusion pumps, medication-delivery systems, and products for surgical and hospital care. The company also provides patient-monitoring and connected-care technologies, including products associated with Hillrom, which Baxter acquired in 2021. Its products and services support healthcare professionals and patients in countries around the world.

Recommended Stories

Earnings History and Estimates for Baxter International (NYSE:BAX)

Receive News & Ratings for Baxter International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Baxter International and related companies with MarketBeat.com's FREE daily email newsletter.